NZ620188B2 - Process for making chitin derivatives - Google Patents

Process for making chitin derivatives Download PDF

Info

Publication number
NZ620188B2
NZ620188B2 NZ620188A NZ62018812A NZ620188B2 NZ 620188 B2 NZ620188 B2 NZ 620188B2 NZ 620188 A NZ620188 A NZ 620188A NZ 62018812 A NZ62018812 A NZ 62018812A NZ 620188 B2 NZ620188 B2 NZ 620188B2
Authority
NZ
New Zealand
Prior art keywords
chitin
mixture
glucosamine
hqe
chitosan
Prior art date
Application number
NZ620188A
Other versions
NZ620188A (en
Inventor
Jaime Lopezcervantes
Original Assignee
Amvac Chemical Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amvac Chemical Corporation filed Critical Amvac Chemical Corporation
Priority to NZ718424A priority Critical patent/NZ718424B2/en
Priority claimed from PCT/EP2012/062238 external-priority patent/WO2012175738A1/en
Publication of NZ620188A publication Critical patent/NZ620188A/en
Publication of NZ620188B2 publication Critical patent/NZ620188B2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)
    • C12N9/20Triglyceride splitting, e.g. by means of lipase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates

Abstract

Disclosed is a process comprising (1) forming an aqueous mixture comprising a microbial composition and solid chitin, wherein said microbial composition comprises one or more microbes that produce chitin digesting enzymes; and (2) fermenting the mixture for a time sufficient to enzymatically digest all or part of the chitin to form a fermented mixture comprising chitosan and glucosamine. In some embodiments, the chitin is derived from the biodegradation of chitin containing marine Arthropods. In other embodiments, the chitin is obtained from chitin containing fungi, filamentous fungi and yeast which is extracted via a chemical process. In yet another embodiment, the chitin is obtained by the biodegradation of chitin containing fungi, filamentous fungi, yeast o and/or insects, preferably using HQE for the digestion. In some embodiments, the process is carried out with a solution that already contains chitosan and/or glucosamine such as HYTb, the aqueous fraction obtained from the biodegradation of chitin containing organisms. all or part of the chitin to form a fermented mixture comprising chitosan and glucosamine. In some embodiments, the chitin is derived from the biodegradation of chitin containing marine Arthropods. In other embodiments, the chitin is obtained from chitin containing fungi, filamentous fungi and yeast which is extracted via a chemical process. In yet another embodiment, the chitin is obtained by the biodegradation of chitin containing fungi, filamentous fungi, yeast o and/or insects, preferably using HQE for the digestion. In some embodiments, the process is carried out with a solution that already contains chitosan and/or glucosamine such as HYTb, the aqueous fraction obtained from the biodegradation of chitin containing organisms.

Description

PROCESS FOR MAKING CHITIN DERIVATIVES BACKGROUND OF THE INVENTION The reader’s attention is also directed to our related divisional New Zealand patent application no. 718424.
Chitin, poly ( β (1-4) - N-acetyl-D-glucosamine) is a natural polysaccharide of mayor importance. This biopolymer is synthesized by an enormous number of living organisms including crustaceans, insects, fungi, filamentous fungi and yeasts. Considering the amount of chitin produced annually in the word, it is the most abundant polymer after cellulose.
The main commercial sources of chitin have been crab and shrimp shell. In industrial processing, chitin is extracted from crustaceans by acid treatment to dissolve calcium carbonate followed by alkaline extraction to solubilize proteins. The most important derivate of chitin is chitosan, obtained by (partial) deacetylation of chitin in the solid state under alkaline conditions (concentrate NaOH) or by enzymatic hydrolysis in the presence of chitin deacetylase.
Under controlled conditions, chitin and chitosan can be polymerized to yield water soluble derivates such as chitin- oligosaccharides (ChOS) and chitosan-oligosaccharides (COS), respectively.
These oligomers are recognized for their bioactivity; including anti-tumor, bactericidal and fungicidal activity, eliciting chitinase and regulating plant growth. Chitin is involved in host defense against bacterial invasion, has been used to prepare affinity chromatography column and is widely used to immobilize enzymes and whole cells.
On account of its biodegradability, non-toxicity, physiological inertness, antibacterial properties, hydrophilicity, gel-forming properties and affinity for proteins, chitin has found applications in many areas other than food such as in biosensors. Chitin–based materials are also used for the treatment of industrial pollutants. Chitin can be processed in form of film and fiber. Regenerated chitin derivative fibers are used as binders in the paper making process, fiber improves the breaking strength of paper.
However, the main development of chitin film and fiber is in medical and pharmaceutical applications as wound-dressing material.
When the degree of deacetylation of chitin reaches about 50% it become soluble in aqueous acidic media and is called chitosan. Chitosan is the only pseudo-natural cationic polymer and thus, it is used many applications. Being soluble in aqueous solution, it is largely used in different applications as solutions, gels, or films and fibers. The main investigations of chitosan concern its preparation with varied molecular weights and deacetylation, the dependence of its solution properties on the deacetylation, the preparation of derivatives and applications.
Chitosan is much easy to process than chitin, but the stability of chitosan materials is generally lower, owing to their more hydrophilic character and, especially, pH sensitivity. Chitosan and its derivatives have various functional properties that have made it possible for them to be used in many fields including, food, cosmetic, biomedicine, agriculture, environment protection and wastewater management.
The most important fields where the specificity of chitosan must be recognized are cosmetic, pharmaceutical and biomedical applications. Drug delivery applications include oral, nasal, parenteral and transdermal administration, implants and gene delivery.
Another point to note is biological activity in regard to agriculture since chitosan exhibits antivirus and antiphage activities. It inhibits the growth of bacterial and bacterial infection, and stimuli the natural defenses in plant. Also is used for the seed coating, frost protection, time releases of fertilizers and nutrients into the soil.
Even though the chitosan is known to have important functional activities, the high molecular weight and high viscosity may restrict the uses in some special fields, particularly in medicine and the food industry, because most animal intestines, especially human gastrointestinal tract, do not possess enzymes such as chitinase and chitosanase, which directly degrade the β-glucosidic linkage in chitin and chitosan. Unlike chitosan, its hydrolyzed products and chitosan oligosaccharides (COS) are readily soluble in water duo their shorter chain length and free amino group in D- glucosamine units. The low viscosity and great solubility of COS at neutral pH have attracted the interest of many researchers to utilize chitosan in its oligosaccharide form.
Especially, in food and nutrition areas have emphasized their ability to improve food and quality and human health progression.
Chemical and enzymatic methods are widely used for COS production and among them chemical hydrolysis is used more commonly in the industrial-scale production. However, chemical hydrolysis has some drawbacks to be commercialized, due to development of toxic compounds, higher risk associated with the environment pollution, and lower production yield. The enzymatic processes are generally carried out in bath and are preferable over chemical methods. This is due to minimized adverse chemical modifications of product during enzymatic hydrolysis.
Other product generated from chitin is glucosamine, IT can be used in agriculture, has shown that the presence of glucosamine in the composition of the soil cause an increment of trichomes absorbent, which is manifested in increased the vigor of the plant. The first reaction can be observed is a strengthening of the tips that take a deep green color, with the border of slightly curly leaves. This is because, when applying glucosamine in the soil, the plant induce a response similar to that which would result when la plant try to defender itself of the attack from fungus, nematodes or insect without these really exist.
In the area of medicine, glucosamine has been used for the treatment for arthritis, promotes the development of the cartilaginous tissue, is used in the reconstruction of cartilage. Glucosamine is involved in the formation of nails, tendons, skin, eyes, bones, ligaments and heart valves, is also implicated in the production of collagen and proteoglycans. [0011A] In this specification where reference has been made to patent specifications, other external documents, or other sources of information, this is generally for the purpose of providing a context for discussing the features of the invention. Unless specifically stated otherwise, reference to such external documents is not to be construed as an admission that such documents, or such sources of information, in any jurisdiction, are prior art, or form part of the common general knowledge in the art. [0011B] In the description in this specification reference may be made to subject matter that is not within the scope of the claims of the current application. That subject matter should be readily identifiable by a person skilled in the art and may assist in putting into practice the invention as defined in the claims of this application.
SUMMARY OF THE INVENTION Generally described are processes for increasing the chitosan and/or glucosamine in HYTb. The process comprises (1) forming a mixture comprising HYTb, a microbial composition and solid chitin, wherein said microbial composition comprises one or more microbes that produce chitin digesting enzymes; and (2) fermenting the mixture for a time sufficient to enzymatically digest all or part of said chitin to form a fermented mixture. The amount of at least one of chitosan and glucosamine in the fermented mixture is greater than in said HYTb.
The present invention relates to a process for increasing the chitosan and/or glucosamine in HYTb comprising: forming a mixture comprising HYTb, a microbial composition comprising HQE (ATCC Deposit Designation PTA-10861), and solid chitin, wherein HYTb comprises the aqueous fraction obtained from the fermentation of chitin-containing Arthropods with a microbial composition comprising HQE (ATCC Deposit Designation PTA-10861); and fermenting said mixture for a time sufficient to enzymatically digest all or part of said chitin to form a fermented mixture wherein the amount of at least one of chitosan and glucosamine in said fermented mixture is greater than in said HYTb.
In an alternative embodiment, the mixture is diluted to form a diluted mixture which is fermented to digest all or part of said chitin to form a fermented mixture. The absolute amount of at least one of chitin and glucosamine (taking into account the dilution step) in the fermented mixture is greater than that in HYTb.
In some embodiments HYTc is the source of said chitin.
Generally, HYTc is micronized to form micronized chitin and residual chitin. The chitin used in the process can be the micronized chitin. However, since this form of chitin has other commercial uses, it is preferred that residual chitin be used in the process. Preferably, HYTc comprises the solid fraction obtained from the fermentation of chitin-containing Arthropods with a microbial composition comprising HQE.
Depending on the extent of the chitin digestion and the ultimate use of the product of the process solids can be separated from the fermented mixture conveniently by centrifugation or filtering. If it is desired that the microbes in the microbial composition be retained, filtration is preferred although low g centrifugation can be used.
The source of chitin need not be from HYTc. For example, chitin derived from filamentous fungi and/or yeasts can be used. See, for example, US Patent 7,556,946 which discloses a chemical process to extract chitin from fungi, including filamentous fungi, and yeasts from groups including Zygomycetes, Basiomycetes, Ascomycetes and Deuteromycetes.
Examples include Aspergillum, Penicillium, Trichoderma, Saccaromyces abd Schizosacaromyces species and edible mushrooms such as Agaricus, Pleurotus, Boletus and Lentinula species. [0017A] The invention also provides a composition comprising a fermented mixture or solution made according to a process of the invention as defined above.
Also described is a process comprising (1) mixing a marine animal or marine animal by-product with a first microbial composition to form a first mixture, where the first microbial composition contains one or more microbes that produce enzymes that digest the marine animal or by-product into solid, aqueous and lipid fractions, wherein the solid fraction comprises chitin and the aqueous phase comprises amino acids, chitosan and glucosamine; (2) fermenting the first mixture; (3) separating the first mixture into solid, aqueous and lipid fractions, where the solid fraction comprises chitin and the aqueous phase comprises chitosan and glucosamine; (4) forming a second mixture comprising the aqueous fraction, chitin and a second microbial composition, where the second microbial composition comprises one or more microbes that produce chitin digesting enzymes; (5) fermenting the second mixture to form a fermented second mixture; and (6) optionally, separating the fermented second mixture into a second aqueous fraction and second solid fraction, where the second aqueous fraction has a higher content of at least one of chitosan and glucosamine as compared to the first aqueous fraction.
The invention also relates to a process comprising: mixing a marine animal or marine animal by-product with a first microbial composition comprising HQE (ATCC Deposit Designation PTA-10861) to form a mixture; fermenting said mixture; separating said mixture into solid, aqueous and lipid fractions, wherein said solid fraction comprises chitin and said aqueous phase comprises chitosan and glucosamine; forming a second mixture comprising said aqueous fraction, chitin and a second microbial composition comprising HQE (ATCC Deposit Designation PTA-10861); fermenting said second mixture to form a fermented second mixture; and optionally, separating said fermented second mixture into a second aqueous and second solid fraction, wherein said second aqueous fraction has a higher content of at least one of chitosan and glucosamine as compared to said first aqueous fraction.
As with the earlier described embodiments, the second mixture can be diluted to form a diluted second mixture which is then fermented to digest all or part of the chitin to form a second fermented mixture. The absolute amount of at least one of chitin and glucosamine in the second fermented mixture is greater than that in said first aqueous fraction.
HYTc is the preferred source of chitin. It can be micronized chitin or residual chitin. Preferably, HYTc comprises the solid fraction obtained from the fermentation of chitin-containing Arthropods with a microbial composition comprising HQE. [0021A] The invention also provides a composition comprising the second fermented mixture or second aqueous fraction made according to a process of the invention as defined above.
Also described is a process comprising (1) forming a mixture comprising a microbial composition and solid chitin, wherein said microbial composition comprises one or more microbes that produce chitin digesting enzymes; and (2) fermenting the mixture for a time sufficient to enzymatically digest all or part of the chitin to form a fermented mixture.
The source of the chitin can be HYTc. Alternatively, the chitin can be derived from fungi, including filamentous fungi, and/or yeasts by a non enzymatic process. See e.g. US Patent 7,556,946. [0022A] The invention also relates to a process comprising: forming a mixture comprising a microbial composition comprising HQE (ATCC Deposit Designation PTA-10861) and chitin, wherein said chitin is derived from a chitin- containing source selected from the group consisting of fungi, filamentous fungi, yeast and insects; and fermenting the mixture for a time sufficient to enzymatically digest all or part of the chitin to form a fermented mixture comprising chitosan and glucosamine.
Also described herein, the chitin and other useful products can be obtained from the biodegradation of chitin containing biological sources such as the fungi, including filamentous fungi, yeast and insects identified above. The process comprises: (1) mixing a chitin containing biological source, such as fungi, including filamentous fungi, yeast and/or insects, with a first microbial composition to form a first mixture, where the first microbial composition contains one or more microbes that produce enzymes that digest the chitin containing biological source into solid, aqueous and optionally lipid fractions, wherein the solid fraction comprises chitin and the aqueous phase comprises amino acids, chitosan and glucosamine; (2) fermenting the first mixture; (3) separating the first mixture into solid, aqueous and optionally lipid fractions, where the solid fraction comprises chitin and the aqueous phase comprises chitosan and glucosamine. [0023A] The invention also provides a composition comprising HYTd, wherein said HYTd comprises the liquid fraction obtained from the fermentation of HYTb and HYTc with HQE (ATCC Patent Deposit designation PTA-10861), wherein said HYTb comprises the liquid fraction obtained from the fermentation of chitin- containing Arthropods with HQE and said HYTc comprises the solid fraction obtained from the fermentation of chitin- containing Arthropods with HQE.
BRIEF DESCRIPTION OF THE DRAWINGS is a flow diagram showing the digestion of crustacean to form HYTb and HYTc. The HYTc and HYTb are subsequently processed with HQE to form HYTd, a solution with relatively high amounts of chitosan and glucosamine as compared to HYTb. depicts the formation of glucosamine as a function of time as compared to HYTb. is a flow diagram showing the digestion of fungi, including filamentous fungi, yeast and/or insects to form HYTb and HYTc. The HYTc and HYTb are optionally processed further with HQE to form HYTd, a solution with relatively high amounts of chitosan and glucosamine as compared to HYTb. depicts a process for making HYTd.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS Generally described is a process comprising (1) forming an aqueous mixture comprising a microbial composition and solid chitin, wherein said microbial composition comprises one or more microbes that produce chitin digesting enzymes; and (2) fermenting the mixture for a time sufficient to enzymatically digest all or part of the chitin to form a fermented mixture comprising chitosan and glucosamine.
In some embodiments, the chitin is derived from the biodegradation of chitin containing marine Arthropods. In other embodiments, the chitin is obtained from chitin containing fungi, filamentous fungi and yeast which is extracted via a chemical process. See e.g. US Patent 7,556,946. In yet another embodiment, the chitin is obtained by the biodegradation of chitin containing fungi, including filamentous fungi, yeast and/or insects as disclosed herein.
The process described may be carried out with a solution that already contains chitosan and/or glucosamine. The degradation of the solid chitin in the process produces more chitosan and/or glucosamine so that the final solution contains higher amounts of these components. In the invention, the chitosan and/or glucosamine containing starting solution is HYTb. The solution obtained after fermentation is referred to as HYTd. HYTd, in some embodiments, is essentially HYTb with a higher concentration of chitosan and/or glucosamine.
If, for example, HYTb contains 1.2 wt% chitosan and 1 wt% glucosamine, the resulting HYTd will contain higher concentrations of one or both of these components, preferably both of the components.
Sources of Chitin 1. Biodegradation of Chitin Containing Arthropods is a flow diagram showing the digestion of crustacean to form HYTb containing chitosan and glucosamine and HYTc which contains solid chitin. This figure also shows the subsequent processing of HYTc and HYTb with the microbial composition HQE to form HYTd, a solution with relatively high amounts of chitosan and glucosamine as compared to HYTb.
Briefly, in the arthropod biodegradation process a microbial composition is used to degrade the arthropod or waste components of the arthropod. It is a lactic acid fermentation process. The microbial composition contains microbes that produce enzymes that can degrade the chitin containing components of the arthropod to chitin, chitosan, N- acetyl glucosamine and glucosamine. It also contains microbes that produce enzymes that can degrade proteins and fats to produce amino acids and lipids. In the invention, the microbial composition for arthropod degradation is referred to as HQE. HQE was deposited with the American Type Culture Collection (ATCC) Manassas, VA, USA on April 27, 2010 and given Patent Deposit Designation PTA-10861.
In a preferred embodiment, the marine arthropod is a crustacean and the preferred crustacean is shrimp. Shrimp by- product comprises shrimp cephalothorax and/or exoskeleton.
In the biodegradation process, it is preferred that the fermentation be facultative aerobic fermentation. It is also preferred that the fermentation is carried out at a temperature of about 30°C to 40°C. The pH is preferably less than about 6, more preferably less than about 5.5. However, the pH should be maintained above about 4.3. The fermentation is carried out for about 24-96 hours. In some embodiments, the fermentation is carried out for about 24-48 hours and more preferably 24-36 hours. These fermentation times are far shorter than the typical prior art fermentation times of 10 to days to achieve substantially the same amount of digestion, albeit without detectable formation of chitosan and glucosamine.
The separation of the mixture is preferably by centrifugation. (e.g. about 920 g). Gravity separation can also be used but is not preferred because of the time required to achieve separation.
The mixture separates in to three fractions: solid, aqueous and lipid. The aqueous fraction comprises protein hydroysate, amino acids, chitosan and The lipid fraction comprises sterols, vitamin A and E and carotenoid pigments such as astaxanthine.
As used herein, the term “HYTb” refers to the aqueous fraction and “HYTc” refers to the solid fraction obtained from the above biodegradation process. This process is described in US Patent Application Serial No. 61/289,706, filed 12/23/09 entitled "Biodegradation of Crustacean By-products", US Patent Application Serial No. 61/299,869, filed 1/29/10 entitled "Biodegradation Process and Microbial Composition" and US Patent Application Serial No. 61/355,365 filed June 16, 2010 entitled “Biodegradation Process and Composition” each of which are incorporated by reference herein in their entirety.
HYTb contains amino acids (about 12 wt%), chitosan (about 0.5- 1.5 wt%), glucosamine (about 0.5-1.5 wt%) and trace elements (about 6 wt%) including calcium, magnesium, zinc, copper, iron and manganese. It also contains enzymes such as lactic enzymes, proteases, lipases, chitinases among others, lactic acid, polypeptides and other carbohydrates.
In addition to the uses described above for chitosan and glucosamine, HYTb alone or in combination with HYTc and the microbial composition HYTa are useful in the treatment of soil, seed, seedlings and foliage as disclosed in US Patent Application Serial No. 61/355,447 filed June 16, 2010 entitled Microbial Process and Composition for Agricultural Use and US patent Application Serial No. 13/160,333 filed June 14, 2011 entitled Microbial Process and Composition, each of which are incorporated herein by reference in their entirety.
HYTd and the chitosan/glucosamine solutions obtained from the microbial digestion of chitin as described herein are similarly useful. See US Patent Application 61/500,543 filed June 23, 2011 entitled Agricultural Uses of HYTd.
It is preferred that HQE be used in the biodegradation process. In other embodiments, it is preferred that previously prepared HYTb be added to HQE or the fermentation broth. As described above, HYTb contains amino acids, chitosan, glucosamine and trace elements including calcium, magnesium, zinc, copper, iron and manganese. HYTb also contains enzymes such as lactic enzymes, proteases, lipases, chitinases, lactic acid, polypeptides and other carbohydrates. HYTb can also contain dormant microorganisms from a prior biodegradation process. Such microorganisms can become reactivated and, in combination with HQE, contribute to a more robust biodegradation process as compared to when HQE is used by itself as otherwise described herein More particularly, the process includes the following steps: a. Activation of the microbial cells in a sugar base solution to enhance its growth and the biomass formation. b. Milling of the shrimp by-products (cephalthorax and exosqueleton) to make a homogeneous paste. c. Homogeneous mixing of the shrimp by-product paste with at least 10% of the activated inoculum. d. Adjustment of the pH values to less than 6.0 in the mixture using a citric acid solution to inhibit the growth of micro organisms and to promote the development of microbial cells that constitute the inoculum. e. Fermentation of the mixture in a non continuous agitated system at temperatures within a range of 30 to 40ºC at least for at least 96 hours maintaining pH at less than 5.0. The pH is monitored periodically. If the pH rises above 5.0, a citric acid buffer is added in an amount to maintain the pH below 5.0. f. Centrifugation of the ferment to separate the three principal fractions: chitin, liquid hydrolysate and pigmented paste. g. Rinsing of the crude chitin and recollection of the rinse water to recuperate fine solids or minerals. h. Drying of the chitin and storage. i. Drying and storage of the liquid hydrolysate. j. The pigmented paste (lipid fraction) is stored in closed recipients for conservation.
The process and operational fundamentals are better understood with reference to the following detailed description.
Activation of microbial cells The microbial compositions as disclosed herein are used as inoculum. The inoculum of HQE has a concentration of microbes of about 2.5 to 3.0% (w/v). HQE is activated by dilution to 5% in sugar cane solution (3.75% final concentration of sugar cane), and incubated at 37 ºC for 5 days. HYTb (10 ml per liter of culture) is preferably added to provide a source of minerals and naturally derived amino acids. The cellular growth of the microorganisms was estimated by optical density measured at 540 nm. The activation is complete at an optical density of about 1.7. The concentration of microbes after activation is about 1.9 to 3.0% (w/v).
Preparation of samples The shrimp by-products samples are obtained from shrimp processing plants. Slightly thawed and minced residue (1500 g by batch) is mixed with 99 grams of sugar cane (final concentration 6.6% wt%) and 85.5 ml of activated HQE 5% (v/w) (optical density of cell = 1.7). Then the pH is adjusted to .5 using 2 M citric acid.
Fermentation control The mixture is incubated at 36 ºC with a non continuous agitation for 96 h. During the fermentation process, the pH is monitored by using a potentiometer, and the total titratable acidity (TTA, %) was determined by titration with 0.1 N NaOH until a pH of 8.5 is obtained. The TTA is expressed as a percentage of lactic acid.
Conditions of separation The fermentation product is a viscous silage which has an intense orange color, due to the astaxanthine presence. The ensilage is centrifuged (5 ºC) at 1250 rpm (930g) for 15 min to obtain the chitin, the liquid hydrolysates, and the pigment paste. The upper phase (pigment paste) is separated manually.
The liquid hydrolysates are separated by decantation, and the sediment that constitutes the raw chitin is washed with distilled water to separate fine solids. The resulting liquid is collected and dried. The raw chitin, liquid hydrolysates and fine solids are dried at 60 ºC. All the fractions are stored to protect them from light. 2. Biodegradation of Chitin Containing Filamentous Fungi, Yeast and Insects The same process is used to enzymatically degrade chitin containing filamentous fungi, yeast and/or insects. is a flow diagram showing the digestion of filamentous fungi, yeast and/or insects to form HYTb and HYTc. The HYTc and HYTb are optionally processed further with HQE to form HYTd, a solution with relatively high amounts of chitosan and glucosamine as compared to HYTb.
Fungi , including filamentous fungi, and yeasts from groups including Zygomycetes, Basiomycetes, Ascomycetes and Deuteromycetes can be used in the biodegradation process.
Examples include Aspergillum, Penicillium, Trichoderma, Saccaromyces abd Schizosacaromyces species and edible mushrooms such as Agaricus, Pleurotus, Boletus and Lentinula species.
A preferred microbial composition to digest fungi, including filamentous fungi, yeasts and insects is HQE 3. Chemical Extraction from fungi and/or yeasts The source of chitin need not be from HYTc. For example, chitin derived from fungi, including filamentous fungi, and/or yeasts can be used. For example, US Patent 7,556,946 discloses a chemical process to extract chitin from fungi, including filamentous fungi, and yeasts from groups including Zygomycetes, Basiomycetes, Ascomycetes and Deuteromycetes.
Examples include Aspergillum, Penicillium, Trichoderma, Saccaromyces abd Schizosacaromyces species and edible mushrooms such as Agaricus, Pleurotus, Boletus and Lentinula species.
Chitin Digesting Microbial Compositions 1. HQE Consortium HQE was deposited with the ATCC on April 27, 2010 and Given Patent Deposit Designation PTA-10861.
HQE was developed, in part, for the biodegradation of chitin containing marine Arthropods such as crustaceans.
However, it has been determined that HQE can also be used to enzymatically convert solid chitin into chitosan and glucosamine. It is believed that other microbial compositions as disclosed herein can be used in the processes disclosed herein.
The following are the microorganisms in HQE which are believed to be involved in the biodegradation process and their known properties. In some cases the strain is identified as “Bioderpac, 2008”. Where the species is not known, the species and strain are identified as “Bioderpac, 2008” Bacillus subtilis (SILoSil BS) is a Gram positive bacterium which is mesophilic and grows at an optimum temperature between 25 and 35°C. It is aerobic and can grow in anaerobic conditions and utilizes a wide variety of carbon sources. It contains two nitrate reductases, one of which is utilized for nitrogen assimilation. It is capable of secreting amylase, proteases, pullulanases, chitinases, xilanases and lipases.
Bacillus thuringiensis (Strains HD-1 and HD-73 (SILoSil BT)) are Gram Positive anaerobic facultative bacteria, in the form of peritrichous flagella. Strains HD-1 and HD-73 synthetizes crystals with diverse geometric forms of proteic and insecticide activity during the spore period. Strains HD- 1 and HD-73 secret exochitanases when in a chitin containing medium and can be utilized for the degradation of the crustacean residues during the production of chitooligosaccharides.
Bacillus cereus (Bioderpac, 2008) is an aerobic facultative bacterium, gram positive, and spore forming. It is mesophilic and grows at an optimum temperature between 20 and 40°C. It produces the antibiotics zwittermicin A and kanosamin.
Bacillus licheniformis (Bioderpac, 2008) is a Gram- positive, motile, spore forming and facultative anaerobic bacterium. It produces bacitracin, alpha amylases, lactamases, proteases and alkaline phosphatases. This is a non-pathogen microorganism that is associated with plants or plant materials.
Bacillus megaterium (Bioderpac, 2008) is a Gram-positive aerobic bacterium. It is considered a saprophyte. It produces glucose dehydrogenase, penicillin amydase, beta-amidase and neutral proteases.
Lactobacillus acidophilus (Bioderpac, 2008) is a member of one of the eight species of lactic acid bacteria. It is Gram positive, non-sporulating and produces lactic acid during fermentation that utilizes lactose as a principal source of carbon to produce energy. It grows with or without the presence of oxygen in an acidic medium (pH 4-5). It produces the bactereocins named lactacin B, organic acids, diacetyls and hydrogen peroxide.
Lactobacillus casei (Bioderpac, 2008) is a mesophilic, facultative anaerobic which is Gram positive and non-spore forming. It has the ability to adapt to cold temperatures. The optimum pH for its growth is 5.5. It ferments galactose, glucose, fructose, manose, manitol, and acetylglucosamine.
This species can be grown over a wide range of pH and temperature. It produces amylase enzymes. It inhibits the growth of pathogenic bacteria such as H. pylori by reducing pH through the production of (1) organic acids such as acetic, proprionic or lactic acid or (2) hydrogen peroxide. This microorganism secrets bacterocines.
Pseudomonas fluorescens (Bioderpac, 2008) is a bacterium with multiple flagellum, forced aerobic and its optimal temperature for growth is between 25 and 35ºC. It produces thermostable lipases and proteases. It is antagonist towards a large number of soil fungus strains. It produces secondary metabolites such as antibiotics, iron chelates, and cyanides.
It produces endochitanase and cellulase in mediums with different glucose concentrations.
Trichoderma harzianum (TRICHOSIL) is a saprophyte fungus. It exhibits antibiotic action and biological competition and for this reason has biological control properties. It produces enzymes that degrade cell walls or a combination of such activities. It produces glucanases, chitinases, lipases, and extracellular proteases when it interacts with some pathogenic fungi, such as Fusarium.
Rhizobium japonicum (Bioderpac, 2008) is a nitrogen fixating bacteria. It synthesizes a hydrogenase system that participates in the recycling of hydrogen to avoid its loss during nitrogen fixation.
Azotobacter vinelandii (Bioderpac, 2008) is an aerobic bacterium. It produces nitrogenases and is capable of nitrogen fixation.
Clostridium pasteurianum (Bioderpac, 2008) is a Gram positive bacteria, anaerobic obligated. It produces ferroxine (an electron transporting protein) that acts as a direct electron donor in the reduction of proteic iron.
Proteus vulgaris (Bioderpac, 2008) Is a gram positive bacteria, anaerobic, facultative that grows at temperatures close to 23ºC. It proteolytically degrades proteins to free amino acids by the enzymes it produces.
Streptomyces sp. (Bioderpac, 2008) is a Gram-positive soil bacterium. It produces multiple enzymes that metabolize diverse nutrients. It can survive significant changes in temperature, humidity and nutrient sources. The extracellular enzymes produced by these bacteria utilize chitin and chitosan as substrates at a pH of 4.5 to 6.5 and at 60ºC. These are conditions generated at the beginning and at the end stages of lactic fermentation in the biodegradation process.
Nitrobacter sp. (Bioderpac, 2008) is Gram negative bacteria, aerobic, which converts nitrites into nitrates. It grows at a pH between 6 and 9 and at temperatures between 10 to 34ºC. The bacteria degrade organic polymers such as chitin into compounds that are utilized by other organisms, such as Pseudomonas fluorescens and Rhizobium japonicum (Bioderpac2008).
Micrococcus sp. (Bioderpac, 2008) is a spheric Gram positive bacterium. This microorganism in association with Streptomyces sp () is capable of degrading colloidal chitin derivatives.
HQE can be used to enzymatically digest chitin. However, of these microbes, it is believed that one, two, three, four or more of the following can be isolated from HQE and used to degrade chitin into chitosan and glucosamine: Bacillus subtilis ( (SILoSil BS), Bacillus thuringiensis (Strains HD-1 and HD-73 (SILoSil BT), Pseudomonas fluorescens (Bioderpac, 2008), Trichoderma harzianum (TRICHOSIL), Streptomyces sp.
(Bioderpac, 2008), and Micrococcus sp. (Bioderpac, 2008). In preferred embodiments the microbial composition contains at least one of, at least two of and preferably each of Bacillus subtilis (SILoSil BS), Bacillus thuringiensis (Strains HD-1 and HD-73 (SILoSil BT) and Trichoderma harzianum (TRICHOSIL).
In yet another preferred embodiment, the microbial composition comprises Trichoderma harzianum (TRICOSIL). 2. Groups and enzymatic activity of microorganisms in HQE The biodegradation of the components of chitin containing arthropods, fungi, filamentous fungi, yeast and/or insects requires hydrolytic enzymes such as proteases, lipases, and chitinases. The following groups and combinations of groups are also useful for the digestion of chitin into chitosan and glucosamine.
The primary group of microbes in HQE comprises Lactobacillus acidophilus (Biodepac 2008), Bacillus subtilis (SILoSil BS), Pseudomonas fluorescens (Biodepac 2008), Bacillus licheniformis (Biodepac 2008) and Trichoderma harzianum (TRICHOSIL). These microorganisms are capable of biodegrading arthropod or arthropod by-products. One or more of the members of this primary group also have a synergistic action when combined with other microorganisms from HQE.
The first group of microorganisms includes microorganisms which cause the reduction of pH and which stabilize fermentation due to the production of organic acids and hydrogen peroxide. This group includes Lactobacillus acidophilus (Biodepac 2008) and Lactobacillus casei (Biodepac 2008). Their activity is important at the start of fermentation and during the final stages of fermentation to produce the optimum pH for the hydrolytic enzymes. Their activity also creates a culture environment which prevents the growth of unwanted microorganisms and favors the demineralization of the chitin residues. Lactobacillus acidophilus (Biodepac 2008) is a member of the primary group.
The second group of microorganisms includes microorganisms which produce extracellular enzymes. This second group includes Bacillus subtilis (SILoSil BS), Bacillus cereus (Biodepac 2008), Trichoderma harzianum (TRICHOSIL), Rhizobium japonicum (Biodepac 2008) and Azotobacter vinelandii (Biodepac 2008). The chitin chains in arthropod or arthropod by-products are associated with protein molecules. The separation of such polymers requires the hydrolytic action obtained from the chitinolytic and proteolytic enzymes produced by these microorganisms. Both types of enzymes break the chains on the internal portion of the polymer to produce oligomers of diverse sizes. The action from these enzymes occurs in a successive manner within the intermediate and final phases of the fermentation process when the appropriate pH conditions are achieved. The microorganisms on this group and the environmental conditions they produce facilitate the liberation of pigments and the lipid fraction adhered to these residues. Bacillus subtilis (SILoSil BS) and Trichoderma harzianum (TRICHOSIL) are members of the primary group.
The third group of microorganisms includes the microorganisms Bacillus licheniformis (Biodepac 2008), Pseudomonas flourescens (Biodepac 2008), Sptreptomyces, (Biodepac 2008) and Clostridium (Biodepac 2008). These microorganisms hydrolyze oligomers (chito-oligosaccharides and peptides) to produce chitobioses, glucosamine, and free amino acids. Bacillus licheniformis (Biodepac 2008) and Pseudomonas flourescens (Biodepac 2008) are members of the primary group.
In preferred embodiments, one or two of the first, second and third groups of microorganisms can be combined.
Alternatively, all of the first, second and third groups can be combined.
A fourth group of microorganisms includes Bacillus thuringiensis (strains HD-1 and/or HD-73), Streptomyces (Bioderpac, 2008), Micrococcus (Bioderpac, 2008), Nitrobacter (Bioderpac, 2008) and Proteus vulgaris (Bioderpac, 2008). The fourth group of microorganisms can be combined with (1) the primary group of microorganisms (2) any of the first, second and third groups of microorganisms (3) the combination of one or two of the first, second and third groups of microorganisms or (4) the combination of all of the first second and third groups. The addition of this fourth group results in a synergistic effect which enhances the biodegradation process.
Each of these groups, including the primary group, is separately useful and can be combined with prior art microbial compositions to enhance their performance. In this regard, the fourth group is particularly preferred.
Table 1 sets forth some of the aforementioned combinations. Column 1 is a list of the known microorganisms in HQE that are believed to be active in the biodegradation process. Column 2 lists the microorganisms from column 1 without the microorganisms in the fourth group of microorganisms. Column 3 shows the combination of the primary microorganisms while columns 4, 5 and 6 identify the combination of microorganisms from the first, second and third groups. Column 4 is the combination of groups 1 and 2; column of groups 1 and 3 and column 6 groups 2 and 3. Other useful combinations are set forth in columns 7-10.
Table 1 Culture Composition 1 2 3 4 5 6 7 8 9 10 Microorganism Bacillus X X X X X X X X subtilis X X X X X X Bacillus cereus Bacillus X X megaterium Azotobacter X X X X X X vinelandii X X X X X X X X Lactobacillus acidophilus Lactobacillus X X X X X X casei Trichoderma X X X X X X X X harzianum Rhizobium X X X X X X japonicum Clostridium X X X X X X pasteurianum Bacillus X X X X X X X X licheniformis Pseudomonas X X X X X fluorescens X X X X X X Bacillus thuringiensis Microorganism 1 2 3 4 5 6 7 8 9 10 X X X X X X X Streptomyces Nitrobacter X X X X X X X X X X Micrococcus Proteus X X X X X vulgaris Particularly preferred cultures are 1-4, 6-8 and 10 The activity of the enzymatic extracts produced by the microorganisms within HQE is complex, but has permitted the degradation of the chitinous residues of arthropods such as crustaceans. The microorganisms in HQE are activated in a successive manner according to the environment generated by the organisms used.
HYTb HYTb contains amino acids (about 12 wt%), chitosan (about 0.5-1.5 wt%), glucosamine (about 0.5-1.5 wt%) and trace elements (about 6 wt%) including calcium, magnesium, zinc, copper, iron and manganese. It also contains enzymes such as lactic enzymes, proteases, lipases, chitinases among others, lactic acid, polypeptides and other carbohydrates. In some embodiments, the degree of acetylation of the produced chitosan is 20% or less, preferably 15% or less, more preferably 10% or less, still more preferably preferable 8% or less and most preferably 5% or less. The specific gravity of HYTb is typically about 1.050-1.054. The average amino acid content in HYTb for certain amino acids is set forth in Table Table 3 Amino acid profile dry powder hydrolysates (mg per g dry weight) Dry powder Amino acid hydrolysates Aspartic acid 38 Glutamic acid 39 Serine 16 Histidine 9 Glycine 28 Threonine 14 Alanine 36.1 Proline 25.8 Tyrosine 70 Arginine 22.2 Valine 20 Methionine 16.4 Isoleucine 18.3 Tryptophan 3.1 Leucine 23 Phenylalanine 39 Lysine 13 Total 431 HYTc The primary component of HYTc is chitin. It has an average molecular weight of about 2300 Daltons and constitutes about 64 wt% of the composition. About 6 % of HYTc contains minerals including calcium, magnesium, zinc, copper, iron and manganese, about 24 wt% protein and 6% water. It has a specific gravity of about 272 Kg/m .
HYTd HYTd is obtained by fermenting chitin with a microbial composition suspended in HYTb. HYTb already contains chitosan (about 0.5-1.5 wt%) and glucosamine (about 0.5-1.5 wt%). The amount of chitosan and glucosamine in HYTd ranges from about 2 wt% to 2.5 wt% chitosan and from about 2 wt% to 5 wt% glucosamine. This represents an increase in the amount of chitosan and glucosamine as compared to HYTb of about 0.5 wt% to 2.5 wt% chitosan and from about 0.5 wt% to 5 wt% glucosamine.
As used herein the term “glucosamine” includes glucosamine or a mixture of glucosamine and N-acetyl glucosamine. In most embodiments, HYTd contains glucosamine and N-acetyl glucosamine.
HYTd can also contain particulate chitin that has not been completely digested. In general the fermentation mixture is filtered to remove large particles of chitin. The filtrate contains usually no more that 2 wt% chitin.
HYTd when undiluted is similar to HYTb in that it contains amino acids (about 12 wt%) and trace elements (about 6 wt%) including calcium, magnesium, zinc, copper, iron and manganese. It also contains enzymes such as lactic enzymes, proteases, lipases, chitinases among others, lactic acid, polypeptides and other carbohydrates. In some embodiments, the degree of acetylation of the produced chitosan is 20% or less, preferably 15% or less, more preferably 10% or less, still more preferably preferable 8% or less and most preferably 5% or less. The average amino acid content in HYTd for certain amino acids is similar to HYTb. See Table 2.
HYTd preferable comprises 12 wt% L-amino acids (Aspartic acid, Glutamic acid Serine, Histidine, Glycine, Threonine, Alanine, Proline, Arginine, Valine, Methionine, Isoleucine, Tryptophan, Phenylalanine, Lysine and threonine) and 5 wt% glucosamine and chitosan. HYTd also preferable contains one or more or all of soluble minerals (P, Ca, Mg, Zn, Fe and Cu), enzymes and lactic acid from the chitin digestion process as well as other polysaccharides.
The fermentation mixture, e.g. HYTb and HQE, can be diluted at the beginning of the chitin digestion process. If diluted, the ration of chitosan and/or glucosamine to amino acids will be higher in the HYTd produced after digestion.
That is dilution before fermentation produces relatively more chitin and/or glucosamine taking into account the dilution factor than if no dilution occurs.
Chitosan/Glucosamine Products When the starting fermentation mixture does not contain chitosan and glucosamine, e.g. when activated HQE is used to digest chitin, the amount of chitosan and glucosamine in the final product ranges from about 0.5 wt% to 1.0 wt% chitosan and from about 0.5 wt% to 1.8 wt% glucosamine. [0088A] The term “comprising” as used in this specification means “consisting at least in part of”. When interpreting each statement in this specification that includes the term “comprising”, features other than that or those prefaced by the term may also be present. Related terms such as “comprise” and “comprises” are to be interpreted in the same manner.
Example 1 Production of chitosan oligosaccharides and glucosamine Chitosan oligosaccharides and glucosamine can be produced under different condition. The hydrolysis time can be varied to find the optimal conditions to produce chitosan and/or glucosamine.
Manual agitation three times a day was used in each of the following experiments. The temperature was 35°C.
Table 2 Treatment Chitin Amino acid Inoculums (HYT-C) (HYT-B Activated for 3 days (HQE) 1 2 % -- 20 1000 ml 0 ml 2 3 % -- 30 1000 ml 0 ml 3 4 % -- 40 1000 ml 0 ml 4 2 % -- 20 970 ml 30 ml 3 % -- 30 970 ml 30 ml 6 4 % -- 40 970 ml 30 ml 7 3% , 1000 ml 0 ml micronized chitin Quantification of glucosamine The analysis of glucosamine is determinate as previously reported Tsuji et al. (1969), with some modifications: Specifically, to a sample of 300 µl, 300 µl KHSO (5%), 300 µl NaOH (5%), is add. The mixture is then left sanding with occasional shaking for 15 min. The excess of nitrous acid is removed by adding 300 µl NH SO NH (12.5%). 300 µl MBTH (0.5%) 4 3 2 is added to the mixture and incubate in a water bath for 60 min. Finally, 00 µl FeCl (0.5%) is add and the absorbance at 653 was read after 30 min against a blank containing water.
Example 2 The following protocol can be used for industrial level production of HYTd with the high concentrations of glucosamine and chitosan. The following table shows the parameters used.
The amount of activated HQE is proportional to that used in Example 1.
Table 3 Parameters of Industrial production Carrier solution: HYT-B 15,000 L Micronized chitin (residuary 300 kg chitin of milling process) Temperature Room temperature (30-35°C) Agitation 8 hours/ daily Production time 7 days Example 3 Production kinetics.
Table 4 shows the production of glucosamine in HYTd as a function of time. Chitin (20 grams) was digested with 30 ml of activated HQE in 970 ml of HYTb.
Table 4 % total of glucosamine Glucosamin Glucosamine Production days (HYTd) e in HYTb produced 3 1.11 0.74 0.37 4 1.54 0.74 0.8 6 1.78 0.74 1.04 7 1.93 0.74 1.19 Days of packaging (approx 20 days) 2.29 0.74 1.55 The results from this experiment are also depicted in Figure 2.
Example 3 One kilogram of residual chitin from HYTc was combined with two liters of HYTb. One liter of activated HQE was added.
After mixing, twenty liters of water was added. The resulting mixture was fermented for six days at 35 to 36 degrees Celsius. This resulted in a solution containing 6 wt% glucosamine and 2 wt% chitosan. See Figure 4.

Claims (20)

WHAT WE CLAIM IS:
1. A process for increasing the chitosan and/or glucosamine in HYTb comprising: forming a mixture comprising HYTb, a microbial composition comprising HQE (ATCC Deposit Designation PTA- 10861), and solid chitin, wherein HYTb comprises the aqueous fraction obtained from the fermentation of chitin-containing Arthropods with a microbial composition comprising HQE (ATCC Deposit Designation PTA-10861); and fermenting said mixture for a time sufficient to enzymatically digest all or part of said chitin to form a fermented mixture wherein the amount of at least one of chitosan and glucosamine in said fermented mixture is greater than in said HYTb.
2. The process of claim 1 wherein said mixture is diluted to form a diluted mixture and said diluted mixture is fermented to digest all or part of said chitin to form a fermented mixture, wherein the absolute amount of at least one of chitin and glucosamine in said fermented mixture is greater than that in said HYTb.
3. The process of claim 1 or 2 wherein HYTc is the source of said chitin, wherein HYTc comprises the solid fraction obtained from the fermentation of chitin-containing Arthropods with a microbial composition comprising HQE.
4. The process of claim 3 wherein said HYTc is micronized to form micronized chitin and residual chitin and said chitin comprises said residual chitin.
5. The process of any one of claims 1 to 4, further comprising separating solids and optionally the microbes and cells from said fermented mixture.
6. A composition comprising the fermented mixture or solution made according to any one of claims 1 through 5.
7. A process comprising: mixing a marine animal or marine animal by-product with a first microbial composition comprising HQE (ATCC Deposit Designation PTA-10861) to form a mixture; fermenting said mixture; separating said mixture into solid, aqueous and lipid fractions, wherein said solid fraction comprises chitin and said aqueous phase comprises chitosan and glucosamine; forming a second mixture comprising said aqueous fraction, chitin and a second microbial composition comprising HQE (ATCC Deposit Designation PTA-10861); fermenting said second mixture to form a fermented second mixture; and optionally, separating said fermented second mixture into a second aqueous and second solid fraction, wherein said second aqueous fraction has a higher content of at least one of chitosan and glucosamine as compared to said first aqueous fraction.
8. The process of claim 7 wherein said second mixture is diluted to form a diluted second mixture and said diluted second mixture is fermented to digest all or part of said chitin to form a second fermented mixture, wherein the absolute amount of at least one of chitin and glucosamine in said second fermented mixture is greater than that in said first aqueous fraction.
9. The process of claim 7 or 8 wherein HYTc is the source of said chitin, wherein HYTc comprises the solid fraction obtained from the fermentation of chitin-containing Arthropods with a microbial composition comprising HQE.
10. The process of claim 9 wherein said HYTc is micronized to form micronized chitin and residual chitin and said chitin comprises said residual chitin.
11. The process of any one of claims 7 to 10, further comprising separating solids and optionally the microbes and cells from said fermented mixture.
12. A composition comprising the second fermented mixture or second aqueous fraction made according to any one of claims 7 to 11.
13. A process comprising: forming a mixture comprising a microbial composition comprising HQE (ATCC Deposit Designation PTA-10861) and chitin, wherein said chitin is derived from a chitin- containing source selected from the group consisting of fungi, filamentous fungi, yeast and insects; and fermenting the mixture for a time sufficient to enzymatically digest all or part of the chitin to form a fermented mixture comprising chitosan and glucosamine.
14. The process of claim 13, further comprising separating the mixture into solid, aqueous and lipid fractions, where the solid fraction comprises chitin and the aqueous phase comprises chitosan and glucosamine
15. A composition comprising HYTd, wherein said HYTd comprises the liquid fraction obtained from the fermentation of HYTb and HYTc with HQE (ATCC Patent Deposit designation PTA-10861), wherein said HYTb comprises the liquid fraction obtained from the fermentation of chitin-containing Arthropods with HQE and said HYTc comprises the solid fraction obtained from the fermentation of chitin-containing Arthropods with HQE.
16. A process as claimed in any one of claims 1 to 5, for increasing the chitosan and/or glucosamine in HYTb, substantially as herein described with reference to any example thereof and with or without reference to the accompanying drawings.
17. A composition as claimed in claim 6 or claim 12, substantially as herein described with reference to any example thereof and with or without reference to the accompanying drawings.
18. A process as claimed in any one of claims 7 to 11, for forming a marine animal or marine animal by-product/HQE microbial composition mixture, substantially as herein described with reference to any example thereof and with or without reference to the accompanying drawings.
19. A process as claimed in claim 13 or claim 14, for forming a chitin/HQE microbial composition mixture, substantially as herein described with reference to any example thereof and with or without reference to the accompanying drawings.
20. A composition as claimed in claim 15, substantially as herein described with reference to any example thereof and with or without reference to the accompanying drawings.
NZ620188A 2011-06-23 2012-06-25 Process for making chitin derivatives NZ620188B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ718424A NZ718424B2 (en) 2011-06-23 2012-06-25 Process for making chitin derivatives

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161500527P 2011-06-23 2011-06-23
US61/500,527 2011-06-23
PCT/EP2012/062238 WO2012175738A1 (en) 2011-06-23 2012-06-25 Process for making chitin derivatives

Publications (2)

Publication Number Publication Date
NZ620188A NZ620188A (en) 2016-05-27
NZ620188B2 true NZ620188B2 (en) 2016-08-30

Family

ID=

Similar Documents

Publication Publication Date Title
US9708634B2 (en) Process for making chitin derivatives
CA2607004C (en) Production of beta-glucans and mannans
EP2515674B1 (en) Biodegradation process and composition
AU2012273927B2 (en) Composition comprising chitosan, glucosamine and amino acids for agricultural use
Arslan et al. Evaluation of sheep wool protein hydrolysate and molasses as low-cost fermentation substrates for hyaluronic acid production by Streptococcus zooepidemicus ATCC 35246
Taser et al. Preparation of chitosan from waste shrimp shells fermented with Paenibacillus jamilae BAT1
US5139949A (en) Anti-microbial and anti-nematode composition, and chitinolytic microorganism for producing the same
NZ620188B2 (en) Process for making chitin derivatives
NZ718424B2 (en) Process for making chitin derivatives
TWI815992B (en) Bacillus licheniformis a6 strain and applications thereof
CN112779178B (en) Bacillus licheniformis A6 strain and application thereof
KR20200027482A (en) Novel chitinase-producing Salinivibrio sp. Kostichola BAO1801 strain and use thereof
KR101113729B1 (en) Process for Preparation of Middle Molecular Chitosan Having Antibacterial Activity against Antibiotic Resistance Bacteria and Uses thereof
KR20190130355A (en) Novel chitinase-producing Salinivibrio sp. Kostichola BAO1801 strain and use thereof
JPH0660B2 (en) Novel microorganism capable of degrading chitin
KR20190016188A (en) Novel chitinase-producing salinivibrio sp. strain and use thereof
Mouafi et al. Extracellular Metabolites Produced by a Novel Strain, Bacillus alvei NRC-14: 4. Antimicrobial Activity of Chitosan Oligosaccharides
BRPI0611535B1 (en) METHOD FOR PROCESSING YEAST CELLS TO PRODUCE BETA-GLUCANS AND MANANAS